Global Glaucoma Treatment Drugs Market Forecast to 202 : Ken Research

1
(No Transcript)
2
Global Glaucoma Treatment Drugs Market Forecast
to 2020 Ken Research

• Ken Research announced its latest publication on
  Global Glaucoma Treatment Drugs Market Outlook
  to 2020 New Product Launches Expected to Boost
  Market provides a comprehensive analysis of the
  glaucoma treatment drugs market. The report
  includes the market share contributed by the
  sales of generic and patented drugs globally for
  treatment of glaucoma.

3
What Is The Potential Of Global Glaucoma
Treatment Drugs Market?

• Glaucoma is defined as a group of disorders of
  optic nerve, which carries information from eye
  to the brain. Major symptom of glaucoma is ocular
  hypertension, which is associated with
  higher-than-normal-pressure inside the eye.
  Moreover, sometimes glaucoma also affects eyes
  with normal eye pressure. If untreated or
  uncontrolled, glaucoma causes peripheral vision
  loss and eventually results in blindness.
  Glaucoma being the second common cause of
  blindness globally has emerged as a worldwide
  problem. The prevalence of glaucoma globally
  among aged population was in 2013. There were
  around million people who were affected with
  glaucoma worldwide in year 2010, which increased
  to million in 2013 and number is expected to
  increase to million by 2020.

4

• The statistics clearly advocates the high demand
  for glaucoma treatment drugs across the globe. It
  has been estimated that glaucoma treatment drugs
  generated USD million of revenue in 2010.
  However, the revenue declined at a high rate till
  2013, owing to the expiry of major patented drugs
  including and . It was observed that market
  exhibited the decline at a rate of from 2011to
  2012 on account of declining sales of . Although
  as a result of increasing prevalence of glaucoma,
  market experienced steady growth afterwards and
  the market was valued at USD million in 2015.
  Aging population and rising awareness in. the
  emerging economies owing to the efforts of the
  government and NGOs were the major reasons which
  assisted the market in its growth during this
  period.

5
Figure Global Glaucoma Treatment Drugs Market On
The Basis Of Revenue In USD Million, 2010 - 2015
6
Which Drug Class Is Generating Maximum Revenue
For Glaucoma Treatment Drugs Market?

• Prostaglandin analogs dominated the glaucoma
  treatment drugs market with revenue share of
  in 2015. The drugs belonging to prostaglandin
  analogs work by increasing the outflow of
  intraocular fluid from the eye. These drugs are
  usually taken as eye drops and preferred for
  people with open angle glaucoma. Presence of two
  patented drugs in this drug class is one of the
  major factors which are responsible for dominance
  of prostaglandin analogs , , and are major
  patented drugs generating revenue for the
  segment. Additionally, which is an off-patented
  drug also generated USD million of the revenue
  in year 2015, contributing a high share in the
  total segment revenue. Beta blockers followed
  prostaglandin analogs with revenue share of in
  2015.This drug class works by decreasing the
  production of intraocular fluid. These drugs are
  majorly available in generic form and are
  relatively inexpensive. This feature of beta
  blockers drug class makes it one of the preferred
  choices of drug in the emerging economies of Asia
  Pacific and Latin America region.

7
Which Geographical Region Dominated The Global
Glaucoma Treatment Drugs Market?

• North America dominated the market with revenue
  share of in 2015. High prevalence of glaucoma,
  high awareness among people and economic
  stability to undergo expensive treatment options
  are the major factors which have driven the
  glaucoma treatment drugs market in North America.
  Approximately million people in the US were
  affected from glaucoma in 2015. Moreover, it has
  been observed that people in the US were blind
  due to glaucoma, accounting for of all the
  blindness cases in 2015.African Americans
  residing in the region are times more likely to
  develop glaucoma than any other descent globally.
  Europe followed North America with revenue share
  of in 2015. Nominal approval regulations and
  easy availability of the drugs in fewer prices in
  the region owing to the reimbursement from the
  government are the major factors which have
  helped the market players to generate high
  revenue in the nation. Aging population is other
  major reason which has resulted in high glaucoma
  prevalence in the region, resulting in demand for
  treatment drugs.

8
What Is The Scenario Of Asia Pacific Region In
Context To Glaucoma Treatment Drugs Market?

• The snapshot on Asia Pacific glaucoma treatment
  drugs market included in study discusses about
  three major markets in the region including
  India, China, and Japan. India though generated
  very low revenue of USD million in 2015 is
  expected to grow at a high pace during the
  forecast period. High prevalence of glaucoma in
  the country coupled with rising awareness is
  expected to fuel the glaucoma treatment drugs
  market in India. Additionally, absence of any
  patented drug and use of only generic products
  has also resulted in low revenue contribution
  from India towards global market. Among generic
  drug manufacturers, dominated the market with
  revenue share of in 2015 followed by , which
  contributed in the total revenue. Carbonic
  Anhydrase inhibitors are estimated to generate
  maximum revenue by drug class contributing in
  the overall revenue in year 2015 in India.

9
How Are Generic Glaucoma Drugs Different From
Branded Glaucoma Drugs?

• Glaucoma being a highly prevalent disease demands
  for effective and affordable treatment options.
  The launch of generic drugs in the market during
  the historical period, especially of Xalatan has
  resulted in decline in revenue share of patented
  drugs in the market from in 2010 to in
  2015. Low cost of generic drugs is the major
  factor which has resulted in high adoption of
  generic drugs in the market. It has been observed
  that branded drugs cost approximately five times
  that of generic drugs

10
How Venturing Of Small Players Is Going To Impact
Global Glaucoma Treatment Drugs Market?

• Glaucoma treatment drugs market is witnessing the
  entry of many small players into the market
  especially in research and development
  activities. These new entrants are conducting
  massive clinical trials for glaucoma treatment
  and their drugs are expected to revolutionize the
  market. Nearly drugs by small companies are
  observed to be in clinical phase III trial and
  are expected to launch during the forecast
  period. The major among them include and by
  Aerie Pharmaceutical and by Inotek
  Pharmaceutical Corporation. Moreover, the drugs
  by belong to new drug class called ROCK
  Inhibitors, which is completely new mechanism of
  treatment for glaucoma.

11
What Would Be The Result Of New Product Launches
On Global Glaucoma Treatment Drugs Market During
The Forecast Period?

• Glaucoma treatment drugs are expected to witness
  growth at a rapid pace. The market is expected to
  grow at a CAGR of from 2016 to 2020 recording
  the market value at USD million in 2016 and USD
  million in 2020. Launch of , , , and are
  expected to generate good amount of revenue
  during the forecast period However, the market
  would be restrained a bit by the patent expiry of
  and . The expected launch of by Bausch
  Lomb Incorporated in 2016 is expected to
  revolutionize the market, as the drug is expected
  to generate sales of nearly billion in year
  2017.It is anticipated that the drug would be
  used as a first-line therapy for the treatment of
  glaucoma. Strong efficacy and simplified
  therapeutic regiment agent presence in the drug
  would increase the use of drug.

12
Key Factors Considered In The Report

• Comprehensive analysis of the Global glaucoma
  treatment drugs market and its segments
• Snapshot on North America Glaucoma Treatment
  Drugs Market
• Snapshot on Europe Glaucoma Treatment Drugs
  Market
• Snapshot on Asia Pacific Glaucoma Treatment Drugs
  Market
• Porters Five Forces Analysis for Global Glaucoma
  Treatment Drugs Market
• Trends and Developments in Global Glaucoma
  Treatment Drugs Market
• Snapshot on Patented Glaucoma Treatment Drugs
  Market
• Generic Versus Branded Glaucoma Drugs
• Pipeline Analysis of Global Glaucoma Treatment
  Drugs Market
• Competitive Landscape and Detailed Company
  Profiles of the Major Market Players
• Future Outlook and Projections of Global Glaucoma
  Treatment Drugs Market
• Analyst Recommendations
• Macro-Economic Factors Impacting the Global
  Glaucoma Treatment Drugs Market

13

• Source https//www.kenresearch.com/healthcare/ph
  armaceuticals/global-glaucoma-treatment-drugs-mark
  et-statistics/47381-91.html
• Contact Ken ResearchAnkur
  Gupta, Head Marketing CommunicationsAnkur_at_kenre
  search.com91-9015378249
• Website www.kenresearch.com

14
Thank you